Stephanie Karzon Abrams
Stephanie Karzon Abrams, a neuropharmacologist with a Masters of Science in Clinical Pharmacology, is the founding advisor of Beyond The Bench consultancy. The firm provides science, research, operations, and strategy solutions to organizations and clinics in the natural product, plant medicine, and psychedelic sectors. A recognized leader in shaping the future of integrative and innovative healthcare, Stephanie Karzon Abrams champions the exploration of novel therapeutic approaches. Her interests extend beyond neurology, encompassing plant medicines, women's health, and the potential of music to enhance healing.
Stephanie Karzon Abrams, a neuropharmacologist with a Masters of Science in Clinical Pharmacology, is the founding advisor of Beyond The Bench consultancy. The firm provides science, research, operations, and strategy solutions to organizations and clinics in the natural product, plant medicine, and psychedelic sectors. A recognized leader in shaping the future of integrative and innovative healthcare, Stephanie Karzon Abrams champions the exploration of novel therapeutic approaches. Her interests extend beyond neurology, encompassing plant medicines, women's health, and the potential of music to enhance healing.
Stephanie is a dedicated advocate for public education and strives to redefine the landscape of health and wellness through open access education and public speaking. Her passions extend to community building, philanthropy, and music, with a particular focus on integrating her passions through unique gatherings and initiatives that foster connection. Stephanie is co-creator of Public Secret, a music label, management agency, and artist collective; Mt. Mushmore, Higher Elevation, a social and educational dinner series; and The Last 6, a community organization that educates and funds research for the acute childhood illness, Kawasaki disease.
Stephanie’s career path transcends traditional boundaries, blending her deep scientific expertise with strategic thinking and a passion for exploring innovative healthcare solutions. Her foundation lies in rigorous research, followed by experience at Johnson and Johnson (Biosense Webster) where she honed her operational, strategic planning, and key opinion leader (KOL) engagement skills. Stephanie’s current work as a prescriber for MDMA and psilocybin therapy for the Canadian Special Access Program (SAP), and her role as a scientific advisor for the Microdosing Collective, exemplifies her commitment to advancing these emerging fields.